AGL
Agilon Health, Inc. Health Care Services-Misc Health & Allied Services, NEC Russell 3000
$84.90Close
$1.4BMarket cap
$7.91 – $129.8452-week range
Nov 4, 2026Next report · after the close
Highlights
Strengths
- Leading the market RS 99 · stronger than 99% of stocks over 12 months
Cautions
- Trend not confirmed 6 of 8 conditions · under the 50-day, over 25% off the high
- Far from its high 35% below its 52-week high
- Results soon Nov 4, 2026, in 3 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
35%
1wk
down 5.4%
price change
1mo
up 6.7%
price change
12-month return
up 325%
market up 11% ·
its own up 282%
F-score
—
— Not assessed
Altman Z″
-7.30
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
11.1×
price / book
Earnings yield
down 37.0%
EBIT / enterprise value
Cheaper than
8%
of the market · expensive
Revenue growth
down 2%
year on year
EPS growth
—
latest quarter
Sales growth
up 7%
latest quarter · +14 pts
ROE
down 131%
return on equity
Free cash margin
down 2%
-$119.0M FCF
D/E
0.12
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 55% ($0.0B → $0.0B)
Trade setup
ATR%
5.9%
$4.97 a day · 2×ATR $74.95
RS
99 / 99
vs the universe
Trend
6 / 8
under the 50-day, over 25% off the high
Relative volume
1.1×
vs 50-day average
Up/down volume
0.69
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 6 of 8
- Price above the 50-day average: fails
- Within 25% of the 52-week high: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Revenue shrinking Revenue fell 2.1% over the year, from $6.1B to $5.9B.
Last reported
Aug 5, 2026
Last shock
Aug 6, 2026-19% in one session2.6× volumeon results-2% since
Financials
- Net -7%
- Free cash -2%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.5B | $2.4B | $4.3B | $6.1B | $5.9B |
| Operating income | -$56.7M | -$372.2M | -$105.4M | -$232.1M | -$292.1M | -$463.2M |
| Net income | -$60.1M | -$406.5M | -$106.6M | -$262.6M | -$260.2M | -$391.3M |
| Net margin | -5% | -27% | -4% | -6% | -4% | -7% |
| Earnings per share | -$4.64 | -$27.25 | -$6.53 | -$16.05 | -$15.83 | -$23.63 |
| Free cash flow | -$55.0M | -$154.7M | -$146.2M | -$172.0M | -$71.0M | -$119.0M |
| Free cash margin | -5% | -10% | -6% | -4% | -1% | -2% |
| Cash | $106.8M | $1.0B | $465.3M | $107.6M | $188.2M | $173.7M |
| Long-term debt | $64.7M | $43.4M | $38.5M | $32.3M | $34.9M | $15.8M |
| Shareholders' equity | -$284.7M | $1.1B | $1.0B | $661.8M | $471.0M | $126.7M |
| Shares outstanding | 9.97m | 16m | 16.50m | 16.26m | 16.49m | 16.59m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 4, 2025 | Quarterly ↗ | Jun 30, 2025 | 35d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Results ↗ |
| Jul 22, 2026 | Director or officer change ↗ |
| Jun 3, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results ↗ |
| Apr 27, 2026 | Director or officer change · Regulation FD ↗ |
| Mar 30, 2026 | Holder rights changed · Charter or bylaws ↗ |
| Mar 18, 2026 | Shareholder vote · Other events ↗ |
| Feb 25, 2026 | Results · Regulation FD ↗ |
| Feb 12, 2026 | Material agreement · New obligation ↗ |
| Jan 7, 2026 | Director or officer change ↗ |
| Nov 7, 2025 | Listing notice · Regulation FD ↗ |
| Nov 4, 2025 | Results · Regulation FD ↗ |